BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8558940)

  • 1. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
    Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of minimal residual disease in a patient with acute promyelocytic leukemia by RT-PCR: necessity of chemotherapy following ATRA therapy.
    Sun T; Takatsuki H; Yamashita S; Yufu Y; Umemura T; Nishimura J; Nawata H
    Fukuoka Igaku Zasshi; 1994 Feb; 85(2):52-6. PubMed ID: 8144129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
    Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR
    Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
    Miller WH; Kakizuka A; Frankel SR; Warrell RP; DeBlasio A; Levine K; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2694-8. PubMed ID: 1372989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
    Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP
    Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse.
    Huang W; Sun GL; Li XS; Cao Q; Lu Y; Jiang GS; Zhang FQ; Chai JR; Wang ZY; Waxman S
    Blood; 1993 Aug; 82(4):1264-9. PubMed ID: 8394752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged molecular remission after PML/RAR alpha-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft?
    Sanz MA; de la Rubia J; Bonanad S; Barragán E; Sempere A; Martín G; Martínez JA; Jiménez C; Cervera J; Bolufer P; Sanz GF
    Leukemia; 1998 Jun; 12(6):992-5. PubMed ID: 9639431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
    Chen SJ; Chen Z; Chen A; Tong JH; Dong S; Wang ZY; Waxman S; Zelent A
    Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho).
    Fukutani H; Naoe T; Ohno R; Yoshida H; Kiyoi H; Miyawaki S; Morishita H; Sano F; Kamibayashi H; Matsue K
    Leukemia; 1995 Apr; 9(4):588-93. PubMed ID: 7723389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia.
    Koller E; Karlic H; Krieger O; Mistrik M; Michlmayr G; Gadner H; Lutz D; Heinz R; Pittermann E
    Ann Hematol; 1995 Feb; 70(2):75-8. PubMed ID: 7880927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-alpha) fusion transcript in patients treated with all-trans retinoic acid followed by chemotherapy.
    Nemet D; Grahovac B; Labar B; Mrsić M; Radman I; Bogdanić V; Hitrec V; Zaher D; Aurer I; Sertić D
    Haematologica; 1995; 80(3):238-40. PubMed ID: 7672716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
    Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
    Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.